SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1229 46 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
991I smell RFKJr’s leadership behind this and so I’m deeply concerned this is not aOlecranon-May 5
990I loathe Adcock and want him so fired for so many reasons, but this event does nFitzhughlaw2May 5
989My thoughts exactly too, and also FML for having posted ra ra support just days TinfoilHat3May 5
988was thinking the same thing ..........luckydog88-May 5
987Well, so much for that “close alignment with the new administration.”jargonweary3May 5
986While disappointing, using this opportunity to average downerippetoe1May 5
985CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc.(IBRX) , a leading immunluckydog881May 5
984The secondary Biotech index [XBI] has been in a 5 year consolidation after toppibobbseytwins20018May 1
983Thanks for the prompt Galt. Busy with work and a 2yo at home makes personal lifeTinfoilHat10May 1
982Agreed and I am still in but damn the cash burn and lack of transparency on forwsukit-May 1
981I doubt it. Maybe the Twins can weigh in. Seems it’s all about getting approvedgalt3April 30
980Guessing he exited. Certainly a frustrating hold. Lots of competition in the blasukit-April 30
979Seems it’s long overdue that tinfoil gives his take on all of this.galt2April 30
978This article published a few days ago could explain some of the recent post-equiMaturin2April 30
977Apr 28, 2025 8:30 AM Eastern Daylight Time Unmatched Long-Term Bladder Preservazagnut13April 28
976Without a big pharma partner the market for Anktiva is growing slower than the mwaitwatchwander1April 25
975I am starting to think that IBRX has a version of the “AUPH disease”. That is, jargonweary-April 25
974That’s ok. I still hold GILD. Thanks for the update. They didn’t miss projectiondorightbythem-April 25
973Sorry I meant to post that on another sitejargonweary-April 24
972finance.yahoo.comjargonweary-April 24
971Good questions but longer term the more important question may be- "What wimannamal-April 23
970The question now is: Will the combination of Tislelizumab (anti-PD-1) and AnktivHuggenberg2April 23
969finance.yahoo.commannamal-April 23
968I wonder if Tinfoil might give us his thoughts on the company, it’s leadership ajargonweary3April 17
967Deleted, wrong thread.waitwatchwander-April 16
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News